Results 1 to 10 of about 10,579 (231)

Sublingual Immunotherapy: Recent Advances

open access: yesAllergology International, 2013
The practice of administering sublingual immunotherapy for respiratory allergy is gaining more and more diffusion worldwide as a consequence of the robust demonstration of clinical efficacy and safety provided by recent high-powered and well-designed ...
Enrico Compalati   +2 more
doaj   +6 more sources

Sublingual immunotherapy for allergy to shrimp: the nine-year clinical experience of a Midwest Allergy-Immunology practice [PDF]

open access: yesAllergy, Asthma & Clinical Immunology
Background Diet restrictions and fear of adverse reactions put a significant burden on the nutrition, growth and life style of children and adults with food allergies.
Lydia M. Theodoropoulou, Niamh A. Cullen
doaj   +2 more sources

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis

open access: yesPathogens, 2022
Sublingual immunotherapy for Japanese cedar pollinosis can improve the symptoms of allergic rhinitis and modify its natural course. However, sublingual immunotherapy requires a long treatment period and some patients do not respond to treatment.
Riyo Yoneda   +8 more
doaj   +1 more source

Eosinophilic esophagitis: A potential complication of sublingual immunotherapy [PDF]

open access: yesOpšta Medicina, 2021
Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk
Knežević Snežana B.   +1 more
doaj   +1 more source

Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status

open access: yesPathogens, 2022
The incidence of Japanese cedar pollinosis is increasing significantly in Japan, and a recent survey suggested that about 40% of the population will develop this disease. However, spontaneous remission is rare.
Daiju Sakurai   +5 more
doaj   +1 more source

Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis

open access: yesFrontiers in Immunology, 2023
BackgroundTo systematically evaluate the clinical efficacy and safety of sublingual immunotherapy for allergic rhinitis (AR) and provide evidence for clinical treatment.MethodsA literature search was performed on the China National Knowledge ...
Zao Ji, Feifei Jiang
doaj   +1 more source

Plant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy: A Case Series

open access: yesPathogens, 2021
Background: Cross-reactivity between pollens and plant food has been widely described. Pollen extract subcutaneous immunotherapy in patients with pollens and plant food allergy has been shown to improve tolerance not only to inhalant allergens but also ...
Fabiana Furci, Luisa Ricciardi
doaj   +1 more source

Sublingual immunotherapy: World Allergy Organization position paper 2013 update

open access: yesWorld Allergy Organization Journal, 2014
We have prepared this document, “Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update”, according to the evidence-based criteria, revising and updating chapters of the originally published paper, “Sublingual Immunotherapy ...
Giorgio Walter Canonica   +24 more
doaj   +1 more source

Critical appraisal of the clinical utility of sublingual immunotherapy in allergy

open access: yesContemporary Clinical Trials Communications, 2016
Since it was introduced by Noon in 1911, allergen-specific immunotherapy or desensitization has been widely prescribed in the management of allergic diseases. Aimed at the etiology, it represents the only effective treatment for allergy.
S. Aissa   +7 more
doaj   +1 more source

Current status of sublingual immunotherapy in the United States

open access: yesWorld Allergy Organization Journal, 2014
Sublingual immunotherapy (SLIT) use in the United States to date has been limited, despite common use and demonstrated efficacy elsewhere in the world.
Shelby Elenburg, Michael S. Blaiss
doaj   +1 more source

Home - About - Disclaimer - Privacy